Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy

BACKGROUND: Non-small cell lung cancer (NSCLC) is the predominant cause of death in patients with COPD, and the severity of COPD in NSCLC patients is classified mainly as mild to moderate. Most advanced NSCLC patients with mild to moderate COPD are treated with chemotherapy; however, the feasibility...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Chron Obstruct Pulmon Dis
Main Authors: Omote, Norihito, Hashimoto, Naozumi, Morise, Masahiro, Sakamoto, Koji, Miyazaki, Shinichi, Ando, Akira, Nakahara, Yoshio, Hasegawa, Yoshinori
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove Medical Press 2017
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729822/
https://ncbi.nlm.nih.gov/pubmed/29270008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S149456
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים